DAY 12 UPDATE
CHALO SANSAD
A peaceful march to the Indian Parliament.
Most countries in the democratic world are not only accessible but welcoming to general public. Most even have a protest place right in front, so there’s no reason this shouldn’t be possible in the capital of the ‘mother of democracy’
I’m mustering all my energy to say these few words… do please watch and comment
Thrilled to share that our research article was the top-read in the Journal of Immunology for March! Huge thanks to my co-authors and everyone who engaged with our work. 🙏 #JournalofImmunology#MIS-C #Immunology#TopRead
We’re sharing the #TopRead articles from March!
Read Dr. Gennaro’s (X: @MarilaGennaro) research, which found that some kids with multisystem inflammatory syndrome carried rare heterozygous variants of LYST that may be a potential driver of #LongCOVID: https://t.co/rzetIV5vJA
सरकार इतना याद रखे की इसी ठसक के साथ देश की संसद में CAA का क़ानून भी लाया गया था और कहा गया था की इस क़ानून के तहत पड़ोसी देशों के हिंदू भाइयों को लाकर नागरिकता दी जाएगी लेकिन इतने दिनों में 2 हज़ार लोग भी नागरिकता लेने नहीं आए ,
लेकिन इससे उलट इस सरकार के दो कार्यकाल में 15 लाख से भी ज़्यादा लोगों ने देश की नागरिकता छोड़ दी !
#WaqfBillAmendment #RejectWaqfBill
We're excited to share our latest research, published in Journal of Immunology "Cryptococcosis, tuberculosis, and a kidney cancer fail to fit the atherosclerosis paradigm for foam cell lipid content." https://t.co/pVGutC3Cvd
Excited to share our latest publication in The Journal of Immunology: 'A genetically modulated Toll-like receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome'
https://t.co/TNjLVaCL9s
#MISC#Immunology#Pediatrics#SARSCoV2
Thrilled to share our latest research paper, titled "IRE1α-XBP1 safeguards hematopoietic stem and progenitor cells by restricting pro-leukemogenic gene programs," published in Nature Immunology!
Link to the paper: https://t.co/M7nPpqV1zp
#Hematopoiesis#StemCells#Leukemia
We encourage original research articles, reviews, case reports, and technical notes that contribute to the Research Topic "Novel Molecular Targets in Cancer Therapy".
https://t.co/BkUaIMsMyf